Irritable Bowel Syndrome
📧 Sign up to get email alerts when something new happens for Irritable Bowel Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-08-28Clinical Trial Update: A Study of YM060 in Diarrhea-predominant Irritable Bowel Syndrome (d-IBS) [Phase 2]
A Phase 2 study evaluating YM060 for diarrhea-predominant irritable bowel syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2014-08-13Clinical Trial Update: Small and Large Bowel Transit Tests Using MRI (Study 1)
The University of Nottingham completed a clinical trial evaluating small and large bowel transit using MRI in Irritable Bowel Syndrome. This…
-
CLINICAL_TRIALS trial_result · 2014-08-05Clinical Trial Update: Study of Bacteria on Mood and Bowel Symptoms in Patients With Irritable Bowel Syndrome [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluated a bacteria-based therapy for mood and bowel symptoms in patients with irritable bowel syndrome; the stu…
-
CLINICAL_TRIALS trial_result · 2014-07-28Clinical Trial Update: Rifaximin 3 Times/Day (TID) for Non-Constipation Irritable Bowel Syndrome (IBS) [Phase 3]
Phase 3 trial update for rifaximin 3 times daily in non-constipation irritable bowel syndrome (IBS) completed with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-07-28Clinical Trial Update: Rifaximin 3 Times/Day (TID) for Non-Constipation Irritable Bowel Syndrome (IBS) [Phase 3]
Phase 3 trial results for rifaximin 3 times daily in non-constipation irritable bowel syndrome have been completed with results posted in 20…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2014-07-16Clinical Trial Update: Efficacy and Safety of Paroxetine Controlled Release for Major Depressive Disorder in Irritable Bowel Syndrome Patients [Phase 4]
Phase 4 trial evaluating paroxetine controlled-release for major depressive disorder in irritable bowel syndrome patients was withdrawn.
-
CLINICAL_TRIALS trial_result · 2014-07-09Clinical Trial Update: An Open Label Trial of Duloxetine in the Treatment of Irritable Bowel Syndrome and Comorbid Generalized Anxiety Disorder [Phase 4]
This is an open-label Phase 4 trial evaluating duloxetine for irritable bowel syndrome with comorbid generalized anxiety disorder. The study…
-
CLINICAL_TRIALS trial_result · 2014-07-02Clinical Trial Update: Brain Imaging, Heart Rate Variability and Serum Fatty Acid in Subjects With Irritable Bowel Syndrome
This completed clinical trial investigated brain imaging, heart rate variability, and serum fatty acids in subjects with irritable bowel syn…
-
CLINICAL_TRIALS research · 2014-07-02Clinical Trial Update: A Study of Xiang-Sha-Liu-Jun-Zi-Tang in Patients With Irritable Bowel Syndrome [Phase 2, Phase 3]
Clinical trial update of Xiang-Sha-Liu-Jun-Zi-Tang for irritable bowel syndrome (Phase 2/Phase 3). Status: UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2014-06-18Clinical Trial Update: Safety and Efficacy of AST-120 in Patients With Non-Constipating Irritable Bowel Syndrome [Phase 2]
A Phase 2 trial evaluating AST-120 in non-constipating irritable bowel syndrome reports safety and efficacy results. The study has completed…
-
CLINICAL_TRIALS trial_result · 2014-05-22Clinical Trial Update: Advanced Metagenomic Analysis of Human Colonic Microbiota in Patients With Chronic GI Disorders
This completed clinical trial analyzed advanced metagenomic profiles of the human colonic microbiota in patients with chronic GI disorders a…
-
CLINICAL_TRIALS trial_result · 2014-05-13Clinical Trial Update: Effects of Relaxation Response Mind-body Intervention in Patients With IBS and IBD [NA]
A completed clinical trial evaluating a relaxation response mind-body intervention in patients with irritable bowel syndrome and inflammator…
-
CLINICAL_TRIALS research · 2014-05-12Clinical Trial Update: A Randomized, Double-blind, and Placebo-controlled Study on the Treatments of Irritable Bowel Syndrome [NA]
This document is a clinical trial update for a randomized, double-blind, placebo-controlled study on treatments for Irritable Bowel Syndrome…
-
FDA approval · 2014-05-08FDA Approved: LOTRONEX — Supplemental Application (Legacy Pharma USA Inc.)
The FDA approved a supplemental application for Lotronex (alosetron hydrochloride) submitted by Legacy Pharma USA Inc.
-
CLINICAL_TRIALS trial_result · 2014-04-28Clinical Trial Update: Tolerability and Effectiveness of Progut in Treatment of Irritable Bowel Syndrome
A completed clinical trial evaluating tolerability and effectiveness of Progut for irritable bowel syndrome.
-
CLINICAL_TRIALS trial_result · 2014-03-27Clinical Trial Update: The Efficacy of Hydrolyzed Guar Gum ( PHGG) in the Treatment of Patients With Irritable Bowel Syndrome (IBS) [Phase 4]
This clinical trial update reports on the efficacy of partially hydrolyzed guar gum (PHGG) for treating irritable bowel syndrome in a Phase …
-
CLINICAL_TRIALS trial_result · 2014-02-25Clinical Trial Update: Proteomics of Cerebrospinal Fluid in Chronic Fatigue Syndrome
Georgetown-sponsored trial investigated proteomics of cerebrospinal fluid in Chronic Fatigue Syndrome and related conditions and has complet…
-
CLINICAL_TRIALS trial_result · 2014-02-12Clinical Trial Update: Efficacy of Mesalamine in Diarrhea-predominant Irritable Bowel Syndrome (dIBS) [Phase 2]
A Phase 2 trial evaluating mesalamine for diarrhea-predominant irritable bowel syndrome has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2014-02-10Clinical Trial Update: Sucrose Breath Test to Determine Intestinal Permeability in IBS
A completed clinical trial evaluating a sucrose breath test to assess intestinal permeability in patients with Irritable Bowel Syndrome.
-
CLINICAL_TRIALS trial_result · 2014-02-05Clinical Trial Update: The Effect of Neu-P11 on Symptoms in Patients With D-IBS
A completed clinical trial evaluating the effect of Neu-P11 on symptoms in diarrhea-predominant irritable bowel syndrome.
-
CLINICAL_TRIALS trial_result · 2014-01-28Clinical Trial Update: Cognition and Emotion in the SII and IBD [NA]
A completed clinical trial investigating cognition and emotion in irritable bowel syndrome and inflammatory bowel disease (including Crohn's…
-
CLINICAL_TRIALS trial_result · 2014-01-28Clinical Trial Update: Cohort Study of Bowel Function Following Robotic-assisted Laparoscopic Sacrocolpopexy
Completed cohort study assessing bowel function after robotic-assisted laparoscopic sacrocolpopexy for pelvic organ prolapse, including effe…
-
CLINICAL_TRIALS trial_result · 2014-01-10Clinical Trial Update: Internet-delivered Cognitive Behavior Therapy for Adolescents With Functional Gastrointestinal Disorders: a Pilot Study [NA]
A completed pilot study assessing internet-delivered cognitive behavioral therapy for adolescents with irritable bowel syndrome and other fu…
-
CLINICAL_TRIALS trial_result · 2014-01-07Clinical Trial Update: Validation of Surrogate Measures in Irritable Bowel Syndrome (IBS) [Phase 4]
This Phase 4 trial update describes the validation of surrogate measures for Irritable Bowel Syndrome. The study is reported as completed.
-
CLINICAL_TRIALS trial_result · 2013-12-24Clinical Trial Update: Milnacipran (Savella) in Irritable Bowel Syndrome (IBS) [Phase 2]
A Phase 2 trial of milnacipran (Savella) for irritable bowel syndrome was terminated, with results posted in 2013.